BioRestorative Therapies
BRTX
13 hedge funds and large institutions have $932K invested in BioRestorative Therapies in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0.77% less ownership
Funds ownership: 9.45% → 8.67% (-0.77%)
7% less funds holding
Funds holding: 14 → 13 (-1)
46% less capital invested
Capital invested by funds: $1.73M → $932K (-$793K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wealth Alliance
Mellville,
New York
|
+$18.3K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$7.18K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.08K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.95K |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
+$4.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Ayrton Capital
Westport,
Connecticut
|
-$69.3K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$33.9K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$4 |
BRTX Hedge Fund Activity: Q2 2022 in Review
13 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2022, worth a combined $932K — down 46% from $1.73M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BRTX and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 6 added.
The largest buyer was Wealth Alliance, adding an estimated $18.3K. The largest seller was Ayrton Capital, cutting an estimated $69.3K.
- 13 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2022, down from 14 in Q1 2022.
- Funds reported $932K of BioRestorative Therapies stock for Q2 2022, down 46% quarter-over-quarter.
- 1 fund opened new BioRestorative Therapies positions in Q2 2022 and 2 closed out, a net change of -1 holder.
- The largest BioRestorative Therapies buyer in Q2 2022 was Wealth Alliance, an estimated $18.3K added.
- The largest BioRestorative Therapies seller in Q2 2022 was Ayrton Capital, an estimated $69.3K sold.
Based on aggregated 13F filings for Q2 2022.